All posts tagged: Covishield

Doctors group raises concerns over Covishield vaccine side effects

Published by Parlour News

A group of doctors under the banner of Awaken India Movement (AIM) have raised concerns over the side effects of Covishield vaccine in the wake of pharmaceutical giant AstraZeneca admitting in a U.K. court that its vaccine can cause blood clots in rare cases. Addressing a press conference here on Wednesday, the group urged the government to “review the science behind all COVID-19 vaccines, including Covishield, that were approved under emergency use authorisation and without completing clinical trials.” “We want the government to audit the commercialisation of COVID-19 vaccines as well as implement an active surveillance and monitoring mechanism to ensure vaccine adverse events are identified as early as possible,” said Veena Raghava and Banu Prakash, doctors who are part of the group. “The government has wholly ignored the rising number of cases of tragic deaths post-COVID vaccination all the while and continues to promote COVID-19 vaccines as ‘safe and effective’, without scientific investigation and invoking epidemiology,” Dr. Prakash said. “The world is learning about a side effect of the vaccine called Thrombosis with Thrombocytopenia …

Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern

Published by Webster

New Delhi: The Supreme Court will hear a petition on a rare side-effect associated with the COVID-19 vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold, in this country, as Covishield.  A date for the hearing has not been set but Chief Justice DY Chandrachud acknowledged the issue, which includes demands for an expert panel to investigate the side-effect and for the government to provide compensation for families of those who may have died after taking the drug. An early hearing of the petition, though, has been ruled out. Specifically, the petitioner has demanded the expert panel probe both the side-effect and other potential risks, and that this investigation be monitored by a retired Supreme Court judge. The petition claims instances where those who took the vaccine also became disabled, and wants directions to the government to provide compensation for them too. Last month AstraZeneca said its vaccine could, in rare cases, cause TTS, or thrombosis with thrombocytopenia syndrome, a condition that leads to …

Covovax vaccine will get approval in next 10-15 days, says SII CEO Poonawalla | Latest News India

Published by Webster

ANI | | Posted by Lingamgunta Nirmitha Rao Chief Executive Officer of Serum Institute of India, Adar Poonawalla, has said their Covovax vaccine will get approval as a booster dose against Covid-19 in the next 10 to 15 days. Poonawalla told the media that the vaccine works very well against the Omicron variant of coronavirus. Speaking to reporters on the sidelines of an event at the Bharati Vidyapeeth University here on Sunday, the SII CEO said: “Central Government has a lot of stock of Covisheild and also Covovax vaccine will get approval as a booster in the next 10 to 15 days.” Also Read | ‘Thank you for saving us’: Devendra Fadnavis to Adar Poonawalla. His reply On being asked about the availability of the Covisheild vaccine, and its lack of supply to the state and district, Adar Poonawalla said, “The central government has a lot of stock of Covisheild they can give it to the state, as of now production of Covisheild is at a halt at SII, we can start it if needed …

‘Thank you for saving us’: Devendra Fadnavis to Adar Poonawalla. His reply | Latest News India

Published by Webster

Maharashtra Deputy Chief Minister Devendra Fadnavis, who shared stage with Serum Institute of India’s Adar Poonawalla for an event in Pune, on Sunday thanked him for his contribution in India’s fight against coronavirus. Serum Institute of India’s Covishield has been one of the two major vaccines that India used for the inoculation program. The other one was Bharat Biotech’s Covaxin. “@adarpoonawalla ji, We always wanted to say Thank You. Entire nation wanted to say Thank You. So, it is on behalf of entire nation we say ‘Thank You for saving us’! (sic)” Fadnavis wrote in a tweet. Sharad Pawar was also seen on stage along with Poonawalla and Fadnavis at the event. To the Maharashtra Deputy CM’s tweet, Adar Poonawalla replied: “I’m humbled by your kind words @Dev_Fadnavis Ji. It has been an honour to serve the nation and we will continue to do so. (sic)” The Serum Institute is the world’s largest vaccine maker. In the United Kingdom and other parts of the world, it collaborated to provide the Oxford–AstraZeneca COVID‑19 vaccine. Meanwhile, speaking …

Can Your Vaccine Protect You Against BF.7? India Isolates New Strain, Begins Study to Test Efficacy

Published by Webster

Last Updated: December 29, 2022, 09:10 IST A health worker administers a dose of Covid-19 preventive vaccine to a citizen at Birsa Munda Football Stadium in Ranchi on Dec 23, 2022. (PTI) Scientists are studying whether the currently available Covid-19 vaccines are effective in preventing infections, a government source was quoted as saying A sample of SARS-CoV-2 virus containing the BF.7, a sub-lineage of the Omicron variant, has successfully been isolated by India to assess the efficacy of available vaccines. Sub-variant BF.7 is suspected to be behind the surge in Covid-19 cases in several countries, including China. A Times of India report quoted government sources as saying that the isolate sample is being studied to assess the efficacy of vaccines. “Scientists are studying whether the currently available vaccines are effective in preventing infections or serious illness caused by the new sub-variant,” a source was quoted as saying. India has reported at least four cases of coronavirus caused by the BF.7 variant since July. However, all the patients were isolated, treated and have recovered. The country …

Serum Institute to Provide 2 Crore Covishield Doses to Central Govt Free of Cost

Published by Webster

Last Updated: December 28, 2022, 19:11 IST SII has so far provided more than 170 crore doses of Covishield to the government for the national immunisation programme. (File pic/PTI) Amid a spike in COVID-19 cases in some countries, including China and South Korea, the government has sounded an alert and asked states and Union territories to prepare for any eventuality The Serum Institute of India (SII) has offered two crore doses of Covishield vaccine to the central government free of cost amid a rise in COVID-19 cases in some countries, official sources said on Wednesday. According to an official source, Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute, has written to the Health Ministry offering the doses worth Rs 410 crore free of cost. It is learnt that Singh has sought to know from the ministry how the delivery can be made. SII has so far provided more than 170 crore doses of Covishield to the government for the national immunisation programme. Amid a spike in COVID-19 cases in some …